Medical and Pharmaceutical New treatments and detection technologies reshape lung cancer care Lung cancer remains the leading cause of cancer death in the United States Joseph Morton4 days ago
Medical and Pharmaceutical bioAffinity jumps 45% from lung cancer phlegm test expansion It is the only commercially available test of its kind Rowan DunneSeptember 2, 2026
Medical and Pharmaceutical Freenome gets FDA breakthrough designation for ‘SimpleScreen’ lung cancer blood test Achievement builds on firm securing agency's approval for a colorectal cancer test variation Rowan DunneAugust 13, 2026
Medical and Pharmaceutical FDA panel to review GRAIL’s Galleri multi-cancer blood test in September The application contains results from more than 70,000 participants enrolled in the intervention arm of the NHS-Galleri trial Joseph MortonAugust 11, 2026
AI and Autonomy Robotic lung biopsy system brings earlier cancer detection closer to patients Lung cancer remains the leading cause of cancer deaths worldwide Joseph MortonJuly 15, 2026
Medical and Pharmaceutical Canadian trial to test blood-based cancer detection in 7,000 survivors SHERLOCK will recruit patients who have already undergone treatments intended to cure their disease Joseph MortonJuly 14, 2026
Medical and Pharmaceutical Emerging biomarkers may improve early colorectal cancer detection and treatment monitoring Colonoscopy remains the gold standard for detecting colorectal cancer Joseph MortonJuly 6, 2026
Medical and Pharmaceutical University of Manitoba researchers develop dual-mode breast cancer imaging system The system uses wave imaging to look inside breast tissue Joseph MortonMay 7, 2026
AI and Autonomy AI-designed drugs near human trials as AlphaFold enters clinical phase Isomorphic Labs launched in 2021 as a unit of Alphabet Inc Joseph MortonApril 29, 2026
Medical and Pharmaceutical New blood test approach could detect multiple cancers earlier, researchers say Scientists have long sought easier ways to identify cancer sooner Joseph MortonApril 27, 2026